39 hours ago · DR Congo
WHO recommends two new Ebola vaccines for clinical trials as DRC battles Bundibugyo outbreak
What's happening
SignalsMonitor is following this as a conflict story. Premium Times Nigeria, UN News All, and ReliefWeb are the outlets attached to this story. The reports are tied to DR Congo. The first report grouped here was at 5 Nov 2026, 03:53 UTC. 3 material updates are listed in the timeline. The headline in use is “WHO recommends two new Ebola vaccines for clinical trials as DRC battles Bundibugyo outbreak”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
He said the Tumaini trial is designed to evaluate multiple vaccine candidates through a ring-vaccination approach involving contacts of people confirmed to have Bundibugyo virus disease. The post WHO recommends two new Ebola vaccines for clinical trials as DRC battles Bundibugyo outbreak appeared first on Premium Times Nigeria.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by ReliefWeb
DR Congo: Two new candidate vaccines to join Ebola trial as treatment research advances
- Picked up by UN News All
- New development reported by Premium Times Nigeria
WHO recommends two new Ebola vaccines for clinical trials as DRC battles Bundibugyo outbreak
Same story, different outlets
3 headlinesEach line is that outlet's headline. The article stays on the publisher's site.